{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:36:55Z","timestamp":1787315815030,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jgo.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T08:04:36Z","timestamp":1563350676000},"page":"311-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["A comparison of three different approaches to defining frailty in older patients with multiple myeloma"],"prefix":"10.1016","volume":"11","author":[{"given":"Ariel","family":"Isaacs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Fiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Tuchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Wildes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2019.07.004_bb0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.1973.03220020026006","article-title":"M-components","volume":"223","author":"Abramson","year":"1973","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.jgo.2019.07.004_bb0010","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Medical progress multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2019.07.004_bb0015","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3324\/haematol.2012.075051","article-title":"Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials","volume":"98","author":"Bringhen","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jgo.2019.07.004_bb0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2141.2006.06042.x","article-title":"Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group","volume":"133","author":"Lenhoff","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jgo.2019.07.004_bb0025","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1056\/NEJMoa1112704","article-title":"Continuous lenalidomide treatment for newly diagnosed multiple myeloma","volume":"366","author":"Palumbo","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2019.07.004_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3324\/haematol.2012.067058","article-title":"Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials","volume":"98","author":"Palumbo","year":"2013","journal-title":"Haematologica."},{"key":"10.1016\/j.jgo.2019.07.004_bb0035","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0801479","article-title":"Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma","volume":"359","author":"San Miguel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2019.07.004_bb0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1200\/JCO.2012.41.6180","article-title":"Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma","volume":"31","author":"Miguel","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.07.004_bb0045","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejca.2009.07.006","article-title":"Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989","volume":"46","author":"Schaapveld","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jgo.2019.07.004_bb0050","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1186\/s12885-018-4807-6","article-title":"Validation of a frailty index in older cancer patients with solid tumours","volume":"18","author":"Mccarthy","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jgo.2019.07.004_bb0055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/gerona\/gls119","article-title":"Searching for an operational definition of frailty: a delphi method based consensus statement. The frailty operative definition-consensus conference project","volume":"68","author":"Rodr\u00edguez-Ma\u00f1as","year":"2013","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.jgo.2019.07.004_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.18.00043","article-title":"Development of a medicare health outcomes survey deficit-accumulation frailty index and its application to older patients with newly diagnosed multiple myeloma","volume":"2","author":"Mian","year":"2018","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.jgo.2019.07.004_bb0065","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.jgo.2019.07.004_bb0070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ."},{"key":"10.1016\/j.jgo.2019.07.004_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arr.2015.12.003","article-title":"Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments","volume":"26","author":"Buta","year":"2016","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jgo.2019.07.004_bb0080","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an international myeloma working group report","volume":"125","author":"Palumbo","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.jgo.2019.07.004_bb0085","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3324\/haematol.2016.162693","article-title":"A concise revised myeloma comorbidity index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients","volume":"102","author":"Engelhardt","year":"2017","journal-title":"Haematologica."},{"key":"10.1016\/j.jgo.2019.07.004_bb0090","doi-asserted-by":"crossref","first-page":"894","DOI":"10.6004\/jnccn.2017.0122","article-title":"Frailty index developed from a cancer-specific geriatric assessment and the association with mortality among older adults with cancer","volume":"15","author":"Guerard","year":"2017","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"key":"10.1016\/j.jgo.2019.07.004_bb0095","article-title":"Geriatric assessment in older adults with multiple myeloma","author":"Wildes","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jgo.2019.07.004_bb0100","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.07.004_bb0105","series-title":"Measuring functioning and well-being: The medical outcomes study approach","first-page":"345","article-title":"Summary and discussion of MOS measures","author":"Stewart","year":"1992"},{"key":"10.1016\/j.jgo.2019.07.004_bb0110","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/geronj\/36.4.428","article-title":"The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire","volume":"37","author":"Fillenbaum","year":"1981","journal-title":"J Gerontol"},{"key":"10.1016\/j.jgo.2019.07.004_bb0115","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/089198879500800408","article-title":"Reliability of the blessed telephone information-memory-concentration test","volume":"8","author":"Kawas","year":"1995","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.jgo.2019.07.004_bb0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u201cup & go\u201d: a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jgo.2019.07.004_bb0125","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0277-9536(91)90150-B","article-title":"The MOS social support survey","volume":"32","author":"Sherbourne","year":"1991","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jgo.2019.07.004_bb0130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jgo.2019.07.004_bb0135","first-page":"741","article-title":"Psychometric evaluation of the functional assessment of cancer therapy\/Gynecologic oncology group - neurotoxicity (fact\/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy","volume":"13","author":"Calhoun","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jgo.2019.07.004_bb0140","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.07.004_bb0145","unstructured":"http:\/\/www.myelomacomorbidityindex.org\/ Engelhardt M, Dold SM, Ihorst G, Knaus J, Schumacher M. R-MCI webpage [Internet]. 2015 [accessed 4 September 2018]."},{"key":"10.1016\/j.jgo.2019.07.004_bb0150","article-title":"Performance of the international myeloma working group myeloma frailty score among patients 75 and older","author":"Murillo","year":"2018","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2019.07.004_bb0155","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3324\/haematol.2016.148189","article-title":"Geriatric assessment in multiple myeloma patients: validation of the international myeloma working group (IMWG) score and comparison with other common comorbidity scores","volume":"101","author":"Engelhardt","year":"2016","journal-title":"Haematologica."},{"key":"10.1016\/j.jgo.2019.07.004_bb0165","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJMsa012528","article-title":"Understanding the treatment preferences of seriously ill patients","volume":"346","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2019.07.004_bb0170","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/10428194.2015.1091933","article-title":"Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: results of the CLL9 trial of the German CLL study group","volume":"57","author":"Goede","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jgo.2019.07.004_bb0175","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood-2012-12-471680","article-title":"Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia","volume":"121","author":"Klepin","year":"2013","journal-title":"Blood."}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406819300190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406819300190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:52:47Z","timestamp":1761817967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406819300190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1879406819300190"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2019.07.004","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparison of three different approaches to defining frailty in older patients with multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}